Shuling Jiang - May 20, 2022 Form 3 Insider Report for ABVC BIOPHARMA, INC. (ABVC)

Role: Director, 10%+ Owner
Signature: /s/ Shuliang Jiang
Stock symbol: ABVC
Transactions as of: May 20, 2022
Transactions value $: $0
Form type: 3
Date filed: 7/12/2022, 05:01 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ABVC	Common Stock						7.91M	May 20, 2022	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Ms. Jiang owns 213,120 shares through Keypoint Technology Ltd., over which she has sole voting control, 538,429 through her 80% ownership of Lion Arts, 6,620,981 through Lion Arts' ownership of YuanGene Corporation, 71,685 shares through her ownership of BioFirst, 1,415 shares through her ownership of BioLite, 381,193 shares through her ownership of Liongene, 12,228 shares through her ownership of Rgene, 5,540 shares through her ownership of Genpro Investment, and 64,215 shares directly.

Content

Ms. Jiang owns 213,120 shares through Keypoint Technology Ltd., over which she has sole voting control, 538,429 through her 80% ownership of Lion Arts, 6,620,981 through Lion Arts' ownership of YuanGene Corporation, 71,685 shares through her ownership of BioFirst, 1,415 shares through her ownership of BioLite, 381,193 shares through her ownership of Liongene, 12,228 shares through her ownership of Rgene, 5,540 shares through her ownership of Genpro Investment, and 64,215 shares directly.